RNA targeting in alpha-synucleinopathies

MICRORNA COMBINATIONS FOR ANTI-CANCER THERAPEUTICS

Reduction of off-target RNA interference toxicity

RAAV-BASED COMPOSITIONS AND METHODS FOR TREATING ALPHA-1 ANTI-TRYPSIN DEFICIENCIES

RECOMBINANT CELLS COMPRISING miRNA MIMICS

Simultaneous detection of cannibalism and senescence as prognostic marker for cancer

Treatment of angiogenesis disorders

Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same

PHARMACEUTICAL COMPOSITIONS COMPRISING MICRORNA

PROCESSES FOR PRODUCING STABLE EXOSOME FORMULATIONS

EXTRACELLULAR VESICLES WITH ENHANCED POTENCY

Methods and compositions for transducing lymphocytes and regulating the activity thereof

NON-VIRAL IPSCS INDUCING COMPOSITION AND KITS

RNAI induced huntingtin gene suppression

CNS targeting AAV vectors and methods of use thereof

NUCLEIC ACID COMPLEX, METHOD FOR FORMING NUCLEIC ACID HYBRIDIZATION, PHARMACEUTICAL COMPOSITION, NUCLEIC ACID PROBE, AND COMPLEMENTARY-STRAND NUCLEIC ACID COMPLEX

Products for the delivery of therapeutic/diagnostic compounds to the heart

Methods of using microRNA-199A

USE OF MICRORNA PRECURSORS AS DRUGS FOR INDUCING CD34-POSITIVE ADULT STEM CELL EXPANSION

Methods of using microRNA-141

Structurally designed shRNAs

Methods and compositions for the activation of gamma-delta T-cells

Preventing and treating inflammatory skin diseases

Combination method for treating cancer by targeting immunoglobulin superfamily member 1 (IGSF1) and mesenchymal-epithelial transition factor (MET)

Methods, systems, and compositions relating to MiRNA-146a

Modulatory polynucleotides

MicroRNA-200 based approaches for modulating bone formation inhibition and bone regeneration

Microrna compositions and methods of making and using same

miRNA transcriptome methods and compositions

POLARIZATION OF MACROPHAGES TO A HEALING PHENOTYPE BY CARDIOSPHERE-DERIVED CELLS AND BY THE EXOSOMES SECRETED BY SUCH CELLS

MiRNA and its diagnostic and therapeutic uses in diseases or conditions associated with melanoma, or in diseases or conditions associated with activated BRAF pathway

MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposes

Nucleic acids related to MiR-29B-1-5P and uses thereof

Enhancing dermal wound healing by downregulating microRNA-26a

COMPOSITIONS AND METHODS FOR TREATING HEPATIC FIBROSIS

Methods and compositions for use of non-coding RNA in cell culturing and selection

Methods and compositions for transducing lymphocytes and regulated expansion thereof

Method for selectively inhibiting ACAT1 in the treatment of neurodegenerative diseases

Cardiosphere-derived cells and exosomes secreted by such cells in the treatment of muscular dystrophy

METHODS TO DETERMINE THE DISTRIBUTION PROFILES OF CIRCULATING MICRORNAS

Polypeptides having beta-xylosidase activity and polynucleotides encoding same

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

BIOLOGICAL CONTROLS OF COLEOPTERAN PESTS

MIR-520B SEQUENCE FOR INHIBITING CANCER GROWTH AND SPREAD AND MEDICINE THEREFOR

TTV miRNA sequences as an early marker for the future development of cancer and as a target for cancer treatment and prevention

Method for non-enzymatic combination of nucleic acid chains

Methods Of Inhibiting Tumorigenesis In Colon Adenocarcinoma And Compositions Therefor

DIAGNOSTIC AND THERAPEUTIC TARGETING OF DNMT-1 ASSOCIATED RNA IN HUMAN CANCER

Oligomeric compounds and compositions for use in modulation of small non-coding RNAs

Bacterially derived intact minicells that encompass plasmid free DNA and methods of using the same

Use of micropeptides in order to stimulate mycorrhizal symbiosis

MicroRNA biomarkers for posttraumatic stress disorder and methods of use thereof

Methods, systems, and compositions for cell-derived/vesicle-based microRNA delivery

MICRORNA WITH PLACENTA-PERMEABILITY AND USES THEREOF

Treatment and biomarker for pulmonary hypoplasia in congenital diaphragmatic hernia

Multiplexed shRNAs and uses thereof

Method for inhibiting Ebola virus via miRNA

Nucleic acid compositions related to MIR-138-1-3P and uses thereof

MicroRNA compounds and methods for modulating miR-21 activity

Treatment of disease by modulation of SIRT6

REGULATION OF MIR-33 MICRORNAS IN THE TREATMENT OF CHOLESTEROL-RELATED DISORDERS

Live attenuated viral vaccine created by self-attenuation with species-specific artificial MicroRNA

PREVENTION OF TUMOUR METASTASIS BY INHIBITION OF NECROPTOSIS

MICRORNAS AND USES THEREOF

Method for modulating plant processes

Therapeutic or prophylactic composition for TDP-43 proteinopathy

COORDINATE CONTROL OF PATHOGENIC SIGNALING BY THE MIR-130/301 FAMILY IN PULMONARY HYPERTENSION AND FIBROPROLIFERATIVE DISEASES

Compositions and methods to treating hemoglobinopathies

MicroRNA compounds and methods for modulating miR-122

miR-96-5p inhibitor and a screening method for the inhibitor

Composition and method of using miR-302 precursors as drugs for treating Alzheimer's diseases

OLIGONUCLEOTIDES FOR MODULATING TARGET RNA ACTIVITY

Methods and compositions for perturbing gene expression in hematopoietic stem cell lineages in vivo

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

MiRNA-489 in treatment of breast cancer

Prophylactic agent and therapeutic agent for fibrodysplasia ossificans progressiva

Use of the chromosome 19 microRNA cluster (C19MC) for treating microbial disease and promoting authophagy

Methods and Compositions for the Treatment of Prostate Related Disorders using miR-106b

Modifications for antisense compounds

TERMINAL MODIFICATIONS OF POLYNUCLEOTIDES

METHODS OF GLUCOCORTICOID THERAPY AND DETERMINING RESPONSIVENESS THEREOF

Nurr1 as a genetic target for treating levodopa-induced dyskinesias in Parkinson's disease

Targeting microRNAs for the treatment of fibrosis

Recombinant AAVS having useful transcytosis properties

Exosomal loading using hydrophobically modified oligonucleotides

Pri-mirna libraries and methods for making and using pri-mirna libraries

Retroviral vector having immune-stimulating activity

Genomic insulator elements and uses thereof

Exon skipping technology in VCP disease

Diagnosis And Treatment Of Cancers With MicroRNA Located In Or Near Cancer-Associated Chromosomal Features

Methods of controlling cell fate and consequences for disease

Composition and method of using miR-302 precursors as anti-cancer drugs for treating human lung cancer

Methods for modulating Ataxin 2 expression

Gene therapy for retinitis pigmentosa

Isolation of novel AAV's and uses thereof

Targeting peptides for directing adeno-associated viruses (AAVs)

Recombinant AAV vectors useful for reducing immunity against transgene products

Isolation of novel AAV's and uses thereof

Micrornas as new therapeutic targets for the prevention and/or treatment of retinopathy

RAAV-BASED COMPOSITIONS AND METHODS FOR TREATING ALPHA-1 ANTI-TRYPSIN DEFICIENCIES

GENERATION OF ARTIFICIAL MICRORNAS

Method of reducing acetylation in plants to improve biofuel production

Cell lines for virus production and methods of use

Ship inhibition to induce activation of natural killer cells

MIR-125A-5P AS A BIOMARKER FOR BREAST CANCER

Lin28/let-7 crystal structures, purification protocols, and molecular probes suitable for screening assays and therapeutics

Transferrin/transferrin receptor-mediated siRNA delivery

Pharmaceutical composition for preventing or treating neurodegenerative diseases

Cell-targeting nanoparticles comprising polynucleotide agents and uses thereof

USE OF AN miRNA TO REDUCE PROLIFERATION OF A CANCER CELL

miRNAs as novel therapeutic targets and diagnostic biomarkers for parkinson's disease

COMPOSITIONS AND METHODS FOR MODULATING MYELOID DERIVED SUPPRESSOR CELLS

Targeting microRNAS for the treatment of liver cancer

METHODS AND COMPOSITIONS FOR INHIBITING INFECTION BY INFLUENZA AND VIRUSES

METHOD FOR PREPARING RECOMBINANT GLYCOPROTEIN HAVING HIGH SIALIC ACID CONTENT, THROUGH GLYCOSPHINGOLIPID SYNTHESIS CYCLE CONTROL

SHIP INHIBITION TO INDUCE EXPRESSION OF GRANULOCYTE COLONY STIMULATING FACTOR IN A SUBJECT

Drug introducing agent for administration into a living body and manufacturing method

Biomarkers and treatments for heart failure

TRANSPOSABLE ELEMENTS, TDP-43, AND NEURODEGENERATIVE DISORDERS

Algal mutants with increased lipid productivity

METHOD OF TREATING HYPERLIPIDEMIA AND ATHEROSCLEROSIS WITH MIR-30C

miRNAs useful for identifying targets associated with cancer

Pharmaceutical use of FAM19A5 involved in regulating gliogenesis

Inhibitors of metastasis

EXPRESSION OF MIRNAS IN PLACENTAL TISSUE

RAAV-based compositions and methods for treating amyotrophic lateral sclerosis

Modulation of human cytomegalovirus replication by micro-RNA 132 (miR132), micro-RNA 145 (miR145) and micro-RNA 212 (miR212)

AAV vectors for retinal and CNS gene therapy

MicroRNA induction of cardiac regeneration

Compounds and methods for enhanced cellular uptake

METHOD OF THERAPY AND DIAGNOSIS OF ENDOTHELIAL DYSFUNCTION

Neurotensin-induced tumor formation is regulated by micro RNA 133A-aftiphilin-dependent receptor recycling

Methods for enhancing or decreasing the levels of MIR124 and MIR29 in subjects with muscular dystrophy

TREATMENT AND PREVENTION OF ADRENOCORTICAL CARCINOMA

MicroRNA composition for the treatment of neuroblastoma

Targeted extracellular vesicles comprising membrane proteins with engineered glycosylation sites

MICRORNA-198 AS A TUMOR SUPPRESSOR IN OVARIAN CANCER

Cell penetrating peptides for intracellular delivery of molecules

Polypeptides having peroxygenase activity

Polypeptides Having Peroxygenase Activity

Colorectal cancer drug, and method for predicting prognosis of colorectal cancer patient

RNA sequence having anti-tumour activity

Methods for selecting competent oocytes and competent embryos with high potential for pregnancy outcome

Invertebrate microRNAs

MicroRNA treatment of fibrosis

Targeting microRNAs for metabolic disorders

MicroRNAs 206 and 21 cooperate to promote RAS-extracellular signal-regulated kinase signaling by suppressing the translation of RASA1 and SPRED1

Methods and compositions for inhibiting retinopathy of prematurity

Polycomb-associated non-coding RNAs

PLANT sRNA EXTRACT FOR USE AS AN IMMUNOSUPPRESSIVE AGENT

Plant sRNA extract or plant miRNA for use as an immunosuppressive agent

miRNAs Enhancing Cell Productivity

Methods and Compositions to Modulate RNA Processing

REDUCING CUTANEOUS SCAR FORMATION AND TREATING SKIN CONDITIONS

NANOPARTICLES FOR TARGETED GENE THERAPY AND METHODS OF USE THEREOF

In vivo Gene Engineering with Adenoviral Vectors

MicroRNA-Based Methods and Compositions for the Diagnosis, Prognosis and Treatment of Ovarian Cancer Using a Real-Time PCR Platform

METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES

OLIGOMERIC COMPOUNDS AND COMPOSITIONS FOR USE IN MODULATION OF SMALL NON-CODING RNAS

Oligomeric compounds and compositions for use in modulation of small non-coding RNAs

Artificial mimic miRNA for controlling gene expression, and use of same

Polypeptides having cellobiohydrolase activity and polynucleotides encoding same

VITAMIN E-BASED NANOCARRIERS FOR DRUG DELIVERY AND METHODS OF MAKING AND USING THE SAME

Methods for treating and/or limiting development of diabetes

Recombinant virus products and methods for inhibition of expression of DUX4

Biomarkers and therapeutic targets for abnormal retinal pigment epithelium

Polycomb-associated non-coding RNAs

METHODS AND COMPOSITIONS FOR THE PRODUCTION OF GUIDE RNA

METHOD OF REGULATING GENE EXPRESSION

Avian influenza virus miRNA, and appraisal, detection, and application thereof

Composition for promoting chondrocyte differentiation or treating cartilage diseases, containing KLF10 expression inhibitor, and method for promoting cartilage differentiation by using same

COMPOSITIONS AND METHODS FOR TREATMENT OF OVARIAN CANCER

MicroRNA expression in human peripheral blood microvesicles and uses thereof

Compositions and methods for inhibition of nucleic acids function

COMBINATION ANTI-HIV VECTORS, TARGETING VECTORS, AND METHODS OF USE

Compositions and methods for treating diabetes

MiRNA modulators of thermogenesis

SMALL RNA, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF IN PHARMACEUTICALS FOR SPECIFICALLY UP-REGULATING GENE TRANSCRIPTIONAL ACTIVITY

Micrornas that silence tau expression

Polycomb-associated non-coding RNAS

Method of treating influenza A

Nucleic acid molecule, expression cassette, expression vector, eukaryotic host cell, induction method of RNA interferencde in eukaryotic host and use of the nucleic acid molecule in therapy of diseases induced by expansion of trinucleotide CAG repeats

Polypeptides having peroxygenase activity

THERAPEUTIC AND DIAGNOSTIC STRATEGIES

COMPOSITIONS AND METHODS FOR DELIVERING MICRORNA

METHODS OF USING STRUCTURALLY INTERACTING RNA

Compositions comprising synthetic polynucleotides encoding CRISPR related proteins and synthetic sgRNAs and methods of use

DIFFERENTIALLY EXPRESSED MICRORNA MOLECULES FOR THE TREATMENT AND DIAGNOSIS OF CANCER

Treatment of disease by modulation of SIRT6

Method for selectively inhibiting ACAT1 in the treatment of obesity, metabolic syndrome, and atherosclerosis

miR-29 mimics and uses thereof

Polycomb-associated non-coding RNAs

MicroRNA-Based Methods and Assays for Osteosarcoma

THERAPEUTIC AND DIAGNOSTIC MOLECULES

Polycomb-associated non-coding RNAs

Alternative export pathways for vector expressed RNA interference

Oligonucleotides and methods for inhibiting or reducing bacterial biofilms

Micro-RNAs and compositions comprising same for the treatment and diagnosis of serotonin-, adrenalin-, noradrenalin-, glutamate-, and corticotropin-releasing hormone- associated medical conditions

Nanoscale carriers for the delivery or co-delivery of chemotherapeutics, nucleic acids and photosensitizers

miR-211 expression and related pathways in human melanoma

Antiviral therapy

Delivery of packaged RNA to mammalian cells

In vitro method for identifying compounds of the Nav 1.9 sodium channel intended for the treatment of an inflammatory skin disease

DOUBLE STRANDED RNA COMPOUNDS TO RHOA AND USE THEREOF

MiRNA for treating diseases and conditions associated with neo-angiogenesis

miR-122* as an active micro-RNA, compositions comprising the same and uses thereof

Conditionally replicating adenovirus

Compositions and Methods for Yeast Extracellular Vesicles as Delivery Systems

RNAi-Related Inhibition of TNF-alpha Signaling Pathway for Treatment of Ocular Angiogenesis

rAAV-based compositions and methods

A Method for Identification of Anti-HIV Human miRNA Mimics and miRNA Inhibitors and Anti-HIV Pharmaceutical Compounds

MicroRNAs and uses thereof

Artificial match-type miRNA for controlling gene expression and use therefor

Sequence-specific inhibition of small RNA function

METHODS OF IMPROVED PROTEIN PRODUCTION USING MIRNAs AND SIRNAs

Regulation of BARD1 expression by non-coding RNA

Therapeutic miRNAs for treating heart and skeletal muscle diseases

Methods of determining eosinophilic gastritis status based on marker or gene expression

Inhibitor for inhibiting avian influenza virus and a pharmaceutical composition containing the same

Recombinant virus products and methods for inhibition of expression of myotilin

Liposomal particles, methods of making same and uses thereof

Nucleic acid inducing RNA interference modified for preventing off-target, and use thereof

Materials and methods for treatment of pulmonary arterial hypertension

Compositions of asymmetric interfering RNA and uses thereof

TOOLS AND METHODS USING MIRNA 182, 96 AND/OR 183 FOR TREATING PATHOLOGIES

METHOD FOR PREDICTING DEVELOPMENT OF MELANOMA BRAIN METASTASIS

UCP1 (THERMOGENIN) - INDUCING AGENTS FOR USE IN THE TREATMENT OF A DISORDER OF THE ENERGY HOMEOSTASIS

Synergistic genome-nonintegrating reprogramming by microRNAs and transcription factors

MICRO-RNAS THAT MODULATE LYMPHANGIOGENESIS AND INFLAMMATORY PATHWAYS IN LYMPHATIC VESSEL CELLS

Mutator Activity Induced by microRNA-155 (miR-155) Links Inflammation and Cancer

PRODUCTION AND UTILIZATION OF A NOVEL ANTI-CANCER DRUG IN THERAPY

Modulation of T cell signaling threshold and T cell sensitivity to antigens

MAGNETIC INORGANIC IRON-BASED NANOPARTICLES

Multi-arm biodegradable polymers for nucleic acid delivery

DNMT inhibitors

METHODS AND COMPOSITIONS FOR MODULATING GENE EXPRESSION USING COMPONENTS THAT SELF ASSEMBLE IN CELLS AND PRODUCE RNAI ACTIVITY

Targeting microRNA-26a/b for the treatment of neurodegenerative disease

Method of using a miR172 Molecule for Decreasing Inflammation

TYRP1, a natural miRNA sponge, and its use in managing human melanoma aggressiveness

Use of microRNA precursors as drugs for inducing CD34-positive adult stem cell expansion

RNA targeting in alpha-synucleinopathies

Compositions and Methods for Diagnosing and Treating Diseases and Disorders Associated With D-DT

Methods for inducing cardiomyocyte proliferation

Block copolymers and uses thereof

Treating hepatitis virus infection by modulating microRNAs miR-130a, miR-130b, miR-204, or miR-1236

MicroRNA-Based Methods and Compositions for the Diagnosis, Prognosis and Treatment of Breast Cancer

MicroRNA compounds and methods for modulating miR-122

MicroRNAs modulating the effect of glucocorticoid signaling

Short hairpin RNA compositions, methods of making and applications thereof

THERAPEUTIC COMPOUNDS

TARGETING GLIOMA STEM CELLS BY SEQUENCE-SPECIFIC FUNCTIONAL INHIBITION OF PRO-SURVIVAL ONCOMIR-138

Compositions and methods for modulating neuronal excitability and motor behavior

TREATING DISEASES ASSOCIATED WITH PGC1-ALPHA BY MODULATING MICRORNAS MIR-130A AND MIR-130B

Microrna inhibition for the treatment of inflammation and myeloproliferative disorders

MicroRNA compounds and methods for modulating miR-21 activity

Bioactive renal cells

THERAPEUTIC USES OF MICROVESICLES AND RELATED MICRORNAS

Compositions and methods to improve the therapeutic benefit of indirubin and analogs thereof, including meisoindigo

Transgenic Plants With Enhanced Traits

Modular RNA regulators and methods

Inhibitors of CACNA1A/ALPHA1A subunit internal ribosomal entry site (IRES) and methods of treating spinocerebellar ataxia type 6

Pri-mirna libraries and methods for making and using pri-mirna libraries

Stem cell microparticles and miRNA

DIAGNOSIS, PROGNOSIS AND TREATMENT OF GLIOBLASTOMA MULTIFORME

Compositions and methods related to miRNA modulation of neovascularization or angiogenesis

Compositions for targeted delivery of siRNA

Single-stranded RNAi agents containing an internal, non-nucleic acid spacer

Nano-constructs for polynucleotide delivery

Use of novel monosaccharide-like glycylated sugar alcohol compositions for designing and developing anti-diabetic drugs

Methods for Diagnosing Prostate Cancer Using MicroRNAs

Methods of modulating compliance of the trabecular meshwork

Ph-sensitive peptides and their nanoparticles for drug delivery

miR-92 inhibitors and uses thereof

Acellular pro-inflammatory compositions, process for making same and methods of using same

Micro-RNA regulation of bone loss

Methods, systems, and compositions relating to miRNA-146a

Method of enhancing miR-185 expression to reduce low density lipoprotein/cholesterol accumulation in a cell

NEW CELL-SPECIFICALLY ACTIVE NUCLEOTIDE MOLECULES AND APPLICATION KIT FOR THE APPLICATION THEREOF

RAAV-based compositions and methods for treating alpha-1 anti-trypsin deficiencies

Methods and Compositions for the Treatment of Prostate Related Disorders using miR-1

Bicyclic morpholino compounds and oligomeric compounds prepared therefrom

AGENTS AND METHODS FOR INHIBITING MIR-148A FOR THE MODULATION OF CHOLESTEROL LEVELS

PLGA-modified polyethylenimine self-assembly nanotechnology for nucleic acid and drug delivery

Esophageal microRNA expression profiles in eosinophilic esophagitis

Methods and Compositions for Increasing the Efficacy of Doxorubicin Treatment in the Treatmentof Prostate Related Disorders using miR-106b-25 Cluster

Organic small hairpin RNAs

Methods and Compositions for the Treatment of Prostate Related Disorders using miR-32

Methods and Compositions for the Treatment of Prostate Related Disorders using miR-106b

Methods of Inhibiting Tumorigenesis in Colon Adenocarcinoma and Compositions Therefor

MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposes

Means and methods for the generation of mammalian producer cells for the production of recombinant proteins

Sphingolipid-polyalkylamine-oligonucleotide compounds

Methods and compositions using miR-3151 in the diagnosis and treatment of thyroid cancer

Compositions of ascorbic acid and bone morphogenetic protein 4 (BMP-4) for cell growth and uses related thereo

TTV miRNA sequences as an early marker for the future development of cancer and as a target for cancer treatment and prevention

PROCESSES FOR PRODUCING EXOSOMES IN REDUCED OXYGEN CULTURE CONDITIONS

PROCESSES FOR PRODUCING STABLE EXOSOME FORMULATIONS

Method of regulating gene expression

ANALYZING METHOD FOR MICRO RNA ID AND BIOMARKERS RELATED TO COLON CANCER THROUGH THIS METHOD

Compositions and methods for treating alzheimer's disease and other tauopathies